Show Description +
Jordi Monés, MD, PhD, discusses novel therapeutic approaches for neovascular AMD. Dr. Monés provides the data on various drugs in phase 1, 2, and 3 trials which are showing promise in improving efficacy as well as duration in AMD treatments.
Posted: 10/16/2020
Jordi Monés, MD, PhD, discusses novel therapeutic approaches for neovascular AMD. Dr. Monés provides the data on various drugs in phase 1, 2, and 3 trials which are showing promise in improving efficacy as well as duration in AMD treatments.
Posted: 10/16/2020
Bryn Mawr Communications, LLC, and Eyetube.net are not affiliated with the official program of EURETINA: 2020.
Please log in to leave a comment.